NILOTINIB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nilotinib, and when can generic versions of Nilotinib launch?
Nilotinib is a drug marketed by Apotex and is included in one NDA.
The generic ingredient in NILOTINIB is nilotinib hydrochloride. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nilotinib hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NILOTINIB?
- What are the global sales for NILOTINIB?
- What is Average Wholesale Price for NILOTINIB?
Summary for NILOTINIB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | NILOTINIB at DailyMed |
US Patents and Regulatory Information for NILOTINIB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | NILOTINIB HYDROCHLORIDE | nilotinib hydrochloride | CAPSULE;ORAL | 203640-001 | Jan 5, 2024 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
| Apotex | NILOTINIB HYDROCHLORIDE | nilotinib hydrochloride | CAPSULE;ORAL | 203640-002 | Jan 5, 2024 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
| Apotex | NILOTINIB HYDROCHLORIDE | nilotinib hydrochloride | CAPSULE;ORAL | 203640-003 | Jan 5, 2024 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Showing 1 to 3 of 3 entries
